trending Market Intelligence /marketintelligence/en/news-insights/trending/A_ZJfZdq2rxrfEUNxD4jTw2 content esgSubNav
In This List

US FDA clears ZELTIQ's fat-removal treatment for upper arms

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


US FDA clears ZELTIQ's fat-removal treatment for upper arms

The U.S. FDA cleared ZELTIQ Aesthetics Inc.'s CoolSculpting, a noninvasive fat-removal technology for upper arms.

The company will also launch the CoolAdvantage Petite applicator for the CoolSculpting system to optimize the performance of CoolSculpting in the upper arms, with full commercial release targeted for the middle of 2017.